Poor Response to Standard Chemotherapy in Early T-precursor (ETP)-ALL: A Subtype of T-ALL Associated with Unfavourable Outcome: A Brief Report

[1]  E. Thiel,et al.  FLT3 Mutations in Early T-Cell Precursor ALL Characterize a Stem Cell Like Leukemia and Imply the Clinical Use of Tyrosine Kinase Inhibitors , 2013, PloS one.

[2]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[3]  W. Hofmann,et al.  Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations , 2012, Blood Cancer Journal.

[4]  Andrew P. Stubbs,et al.  Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. , 2011, Cancer cell.

[5]  T. Lipp,et al.  Successful Subtype Oriented Treatment Strategies in Adult T-All; Results of 744 Patients Treated in Three Consecutive GMALL Studies. , 2009 .

[6]  C. Bloomfield,et al.  Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia , 2009, Haematologica.

[7]  A. Ferrando,et al.  WT1 mutations in T-ALL. , 2009, Blood.

[8]  J. Taub.  Early T-cell precursor acute lymphoblastic leukaemia. , 2009, The Lancet. Oncology.

[9]  Cheng Cheng,et al.  Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. , 2009, The Lancet. Oncology.

[10]  T. Ikawa,et al.  Adult T-cell progenitors retain myeloid potential , 2008, Nature.

[11]  Ellen V. Rothenberg,et al.  Launching the T-cell-lineage developmental programme , 2008, Nature Reviews Immunology.

[12]  C. Bloomfield,et al.  Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  I. Magrath,et al.  Result of childhood acute lymphoblastic leukemia protocol (INCTR) from a developing country , 2007 .

[14]  Christopher B. Miller,et al.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.

[15]  M. Schrappe,et al.  Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Ching-Hon Pui,et al.  Acute lymphoblastic leukemia. , 2004, The New England journal of medicine.

[17]  J. Downing,et al.  Satelite Symposium V, Meet-the-Professor Sessions I and II, Main Sessions I-IX , 2004, Annals of Hematology.

[18]  P. Bolufer,et al.  Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. , 2004, Haematologica.

[19]  L. Kumar,et al.  Lympho-hemopoietic malignancies in India , 2002, Medical oncology.

[20]  W. Hiddemann,et al.  Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. , 2000, Blood.

[21]  M. Andreeff,et al.  Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.